Justin and Marshall Innovision

JOHNS ISLAND, SC, June 2019 – Okra Medical, an innovator in controlled substance disposal solutions, today announced the appointment of the following executives to its advisory board:

  • Mark Harvill, CEO,  Avomeen Analytical
  • Andrew Kolbert, PhD, M.T.M., President and CEO, Avomeen Analytical
  • David Wanetick, CEO , IncreMental Advantage

The advisory board provides insight to Okra Medical’s leadership team on the company’s strategic planning and product innovation.
Mr. Harvill has held leadership positions in global contract research organizations (CROs) for the past 23 years. His career milestones include securing approvals for three of the world’s top-selling drugs. As CEO of Avomeen, Mr. Harvill leads the company’s vision and strategy to drive product innovation.

Mr. Kolbert has 20 years’ experience managing analytical and product development programs. As an expert in analytical chemistry, he focuses on pharmaceutical development and testing, food contact migration studies, extractables and leachables studies, food additive and food contact notification testing and registration, and pesticide and insecticide testing under FIFCA.

Mr. Wanetick is a recognized expert in valuing emerging technologies, intellectual property, and intangible assets. For more than 20 years, he has negotiated licensing transactions, spin-offs, capital raises, joint-ventures, and exits alongside and against Fortune 500 companies, government entities, universities, commercial bankers, private equity firms and venture capitalists. He is the author of seven books, most recently “Plight of the Patentee.”

About Okra Medical Inc.
Okra Medical, Inc., headquartered in Johns Island, South Carolina, specializes in product development, manufacturing and strategic sourcing of controlled pharmaceutical substance disposal solutions. Founded in 2018, the company’s mission is to improve public health by bridging science and innovation. Its best-in-class suite of SafeMedWaste products use single formulas that are fully compliant with DEA regulations requiring non-retrievable destruction and disposal of controlled substances. Okra Medical is a strategic sourcing partner to hospitals, hospice facilities, law enforcement agencies, pharmaceutical manufacturers, and veterinary care clinics. Visit www.okramedical.com